Results 61 to 70 of about 3,960 (190)
The study objective was to examine natural variation of the patient-reported outcome measures fatigue, pain, patient global assessment (PaGl) and the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with stable axial spondyloarthropathy ...
Ole Rintek Madsen, Madsen, Ole Rintek
core +1 more source
ABSTRACT Aim The objective was to evaluate biologic disease‐modifying antirheumatic drugs (DMARDs) and their side effects that hindered the continuation of treatment in a patient population diagnosed with spondyloarthritis (SpA) with a glomerular filtration rate (GFR) ≤ 60 mL/min, and to compare these side effects between patients with chronic kidney ...
Dilara Bulut Gökten +23 more
wiley +1 more source
Objective The Assessment of Spondyloarthritis International Society Health Index (ASAS HI) is a validated patient‐reported outcome (PRO) for global functioning of patients with axial spondyloarthritis (axSpA). The Epionics SPINE (ES) is an electronic device for assessment of axial mobility that provides an objective measure of spinal mobility by ...
David Kiefer +11 more
wiley +1 more source
Objective. Disability has been identified as a core outcome measure in ankylosing spondylitis (AS). The Dougados Functional Index (DFI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) have been selected as core measures of function in this ...
Helliwell PS +4 more
core +5 more sources
Objective To assess the impact of bimekizumab on physical functioning, sleep, work productivity and overall health-related quality of life (HRQoL) in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA) in the phase ...
Annelies Boonen +12 more
doaj +1 more source
Introduction Ankylosing spondylitis (AS) is a lifelong condition where spinal inflammation causes chronic back pain and restriction of spinal function.
Johannes C. Nossent +2 more
doaj +1 more source
Disrupted gut microbiota and altered metabolites are present in AS patients. The analysis of microbiome and metabolomic data revealed significant differences between AS patients and HCs. ABSTRACT Objective Despite growing interest in the gut microbiota and blood metabolome in patients with ankylosing spondylitis (AS), its role remains poorly understood.
Xin Wang +8 more
wiley +1 more source
Objectives: The primary aim of this study was to assess the possible relationship among the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI), and two Ankylosing Spondylitis Disease ...
Saliha EROĞLU DEMİR +10 more
doaj
Abstract Background Gender‐ and sex‐specific differences in medicine were long‐time disregarded. Despite numerous indications of gender‐ and sex‐specific influences on the treatment of dermatological conditions, these have not yet been systematically investigated.
S. Preis +4 more
wiley +1 more source
Fatiga en pacientes con espondiloartritis: datos en un centro de atención terciaria en Brasil
Introducción: la fatiga es frecuente en los pacientes con espondiloartritis axial (SpA), afectando la calidad de vida y su causa no es completamente comprendida. Objetivos: estudiar factores asociados a fatiga en pacientes con SpA.
Thelma Larocca Skare +5 more
doaj +1 more source

